Breast Carcinoma — Trials

Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 873
Recruiting: 478
Ph III recruiting: 55
Growth YoY: −2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04547907	A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer	recruiting	Phase 3	688	Henan Cancer HospitalOTHER_GOV	1	Sep 20, 2024	clinicaltrials
NCT06313086	DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer	recruiting	Phase 3	442	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY	1	May 10, 2024	clinicaltrials